decisionhealth Newsletters, Coder Pink Sheets - 2009 Issue 7 (July)
Diagnosis coding for cystic fibrosis carrier screenings
Subscribe or sign in to view the full article.
Article Overview
This short coding article addresses how cystic fibrosis screening services are discussed in relation to diagnosis coding and patient billing coverage. It is aimed at ObGyns, coders, and billing staff who need to understand the general distinction between carrier testing and disease screening, along with the role of ACOG guidance and an official committee opinion.
Why This Topic Matters
Accurate diagnosis coding for genetic and screening services affects claim processing, patient responsibility, and alignment with specialty guidance. The article is relevant for practices that offer cystic fibrosis-related testing and need to understand how the documentation context influences coding.
What You Will Learn
- How cystic fibrosis screening services are discussed in billing and coverage contexts
- The general difference between carrier testing and disease screening as presented in the article
- Which professional guidance document is referenced for this topic
- How the article frames diagnosis coding in relation to procreative management testing
Who Should Read This
- ObGyn physicians
- Medical coders
- Medical billers
- Practice managers
- Genetic counseling staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com